Compare Nippon India Pharma Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.81 | 1.93 |
NAV | ₹497.86 | ₹37.55 |
Fund Started | 10 May 2004 | 25 Jun 2018 |
Fund Size | ₹8688.65 Cr | ₹5024.00 Cr |
Exit Load | Exit load of 1% if redeemed within 1 month. | Exit load of 1% if redeemed within 15 days. |
Returns
1 Year | 37.77% | 50.65% |
3 Year | 18.22% | 22.29% |
5 Year | 27.85% | 30.36% |
Holding Analysis
Equity | 95.60% | 97.87% |
Cash | 4.38% | 2.13% |
Top Holdings
Top 10 Holdings |
|
|
Fund Manager
Name | Akshay Sharma | Dharmesh Kakkad |
Start Date | 01 Dec 2022 | 23 Feb 2021 |
About Fund
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 10 May 2004 | 25 Jun 2018 |
